Hostname: page-component-586b7cd67f-dlnhk Total loading time: 0 Render date: 2024-11-25T02:05:19.346Z Has data issue: false hasContentIssue false

Modification of WTO Rules on Protection of Pharmaceuticals

Published online by Cambridge University Press:  10 March 2017

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Contemporary Practice of the United States Relating to International Law
Copyright
Copyright © American Society of International Law 2003

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1 Agreement on Trade-Related Aspects of Intellectual Property Rights, Apr. 15,1994, Art. 27(1), Marrakesh Agreement Establishing the World Trade Organization, Annex 1C, in WORLD TRADE ORGANIZATION, THE LEGAL TEXTS: THE RF.SU LTS OF THE URUGUAY ROUND OF MULTILATERAL TRADE NEGOTIATIONS 365 (1999), reprinted in 33ILM 81 (1994).

2 Id., Art. 31(f).

3 See id., An. 68.

4 Declaration on the TRIPS Agreement and Public Health, para. 6, WTO Doc. WT/MIN(01) /DEC/2 (Nov. 20, 2001), reprinted in 41 ILM 755 (2002), at <http://www.wto.org>.

5 See Paragraph 6 of the Doha Declaration on the TRIPS Agreement and Public HealthSecond Communication from the United States, WTO Doc. IP/C/W/358 (July 9,2002), a£ <http://www.wto.org>; see also Elizabeth Becker, Poor Nations Can Purchase Cheap Drugs Under Accord, N.Y. TIMES, Aug. 31, 2003, at 6.

6 WTO General Council, Decision of 30 August 2003, WTO Doc. IP/C/W/405 (Aug. 30,2003) (footnotes omitted), at <http://www.wto.org>.

7 WTO Press Release on the General Council Chairperson's Statement (Aug. 30, 2003), «<http://www.wto.org>.

8 Office of the U.S. Trade Representative Press Release on Statement of Ambassador Linnet F. Deily, Permanent Representative to the World Trade Organization and Deputy U.S. Trade Representative, Following Agreement in WTO on Access to Medicines (Aug. 30, 2003), at <http://www.ustr.org>.

9 These states included Australia, Canada, Iceland, Japan, New Zealand, Norway, Switzerland, and the United States, as well as current and soon-to-accede members of the European Union.

10 Among these states were China (including Hong Kong and Macao), Israel, Korea, Kuwait, Mexico, Qatar, Singapore, Turkey, and United Arab Emirates, as well as Chinese Taipei.